Co-Diagnostics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $641 | $161 | $252 | $3,555 |
Gross Profit | 343 | -389 | -312 | 274 |
EBITDA | -9,883 | -7,341 | -9,928 | -11,512 |
EBIT | -10,234 | -7,679 | -10,259 | -11,825 |
Net Income | -9,696 | -7,599 | -9,312 | -14,676 |
Net Change In Cash | 641 | 161 | 252 | 3,555 |
Free Cash Flow | -7,403 | -5,302 | -8,892 | -5,243 |
Cash | 10,797 | 13,858 | 23,099 | 14,916 |
Basic Shares | 30,494 | 30,124 | 29,842 | 31,259 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $6,812 | $34,218 | $97,885 | $74,552 |
Gross Profit | 2,627 | 28,737 | 86,310 | 57,961 |
EBITDA | -41,475 | -10,308 | 46,400 | 41,832 |
EBIT | -42,706 | -11,621 | 46,064 | 41,693 |
Net Income | -35,332 | -14,238 | 36,658 | 42,478 |
Net Change In Cash | 6,812 | 34,218 | 97,885 | 74,552 |
Cost of Revenue | -65,633 | 45,630 | 42,083 | |
Free Cash Flow | -23,447 | 5,141 | 40,411 | 27,390 |
Cash | 14,916 | 22,973 | 88,607 | 42,976 |
Basic Shares | 29,346 | 31,479 | 29,903 | 28,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.32 |
2024-06-30 | -$0.14 |
2024-03-31 | -$0.31 |
2023-12-31 | -$0.50 |
